48 results
Page 2 of 3
8-K
EX-99.1
xky274ch4 uu1go57
26 Feb 19
Clovis Oncology Announces 2018 Operating Results
8:15am
8-K
EX-99.1
rq621
30 Oct 18
Clovis Oncology Announces Third Quarter 2018 Operating Results
4:06pm
8-K
EX-99.2
2l3b4xeje vdrz
2 Jun 14
Other Events
12:00am
8-K
EX-99.1
kd0y35veej jabn5ui
2 Jun 14
Other Events
12:00am
8-K
zop 67v39s41ztkmav
2 Jun 14
Other Events
12:00am
8-K
EX-99.3
d8oci syqsfnpw
2 Jun 14
Other Events
12:00am
8-K
EX-99.1
794koplqx6kojlrw4dlu
31 Oct 13
Clovis Oncology Announces Third Quarter 2013 Operating Results
12:00am
8-K
EX-99.1
r3ud199tap6m g8j
1 Aug 13
Clovis Oncology Announces Second Quarter 2013 Operating Results
12:00am
424B5
2lrbmuttywp54wkoq
12 Jun 13
Prospectus supplement for primary offering
12:00am
424B5
439 t5pwe6
12 Jun 13
Prospectus supplement for primary offering
12:00am
424B5
yung k657lgzr9le
10 Jun 13
Prospectus supplement for primary offering
12:00am
8-K
3wqtwzkrg wq
3 Jun 13
Clovis Oncology’s CO-1686 Demonstrates Encouraging Results from Ongoing Phase I/II Study in EGFR-mutant Non-Small Cell Lung Cancer
12:00am
8-K
uja80dvpuu98bmuo
3 Jun 13
Clovis Oncology’s Rucaparib Demonstrates Encouraging Results from Ongoing Phase I/II Monotherapy Study in Patients with Solid Tumors
12:00am
8-K
EX-99.1
talejf g33
3 Jun 13
Clovis Oncology’s CO-1686 Demonstrates Encouraging Results from Ongoing Phase I/II Study in EGFR-mutant Non-Small Cell Lung Cancer
12:00am
8-K
EX-99.1
zs070whgqzyp
3 Jun 13
Clovis Oncology’s Rucaparib Demonstrates Encouraging Results from Ongoing Phase I/II Monotherapy Study in Patients with Solid Tumors
12:00am